Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Other Accumulated Expenses (2020 - 2025)

Journey Medical's Other Accumulated Expenses history spans 6 years, with the latest figure at $455000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Other Accumulated Expenses fell 13.83% year-over-year to $455000.0, compared with a TTM value of $455000.0 through Dec 2025, down 13.83%, and an annual FY2025 reading of $455000.0, down 13.83% over the prior year.
  • Other Accumulated Expenses for Q4 2025 was $455000.0 at Journey Medical, up from $359000.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $2.7 million in Q1 2022, with the low at $195000.0 in Q4 2023.
  • Average Other Accumulated Expenses over 5 years is $732166.7, with a median of $559500.0 recorded in 2022.
  • Year-over-year, Other Accumulated Expenses tumbled 75.32% in 2023 and then surged 263.64% in 2025.
  • Tracing DERM's Other Accumulated Expenses over 5 years: stood at $450000.0 in 2021, then decreased by 8.22% to $413000.0 in 2022, then crashed by 52.78% to $195000.0 in 2023, then surged by 170.77% to $528000.0 in 2024, then dropped by 13.83% to $455000.0 in 2025.
  • Per Business Quant, the three most recent readings for DERM's Other Accumulated Expenses are $455000.0 (Q4 2025), $359000.0 (Q3 2025), and $561000.0 (Q2 2025).